Vinblastine treatment of Hodgkin's disease. Selected observations of vinca alkaloid dose schedules in man and animals.
D000818:Animals; D004305:Dose-Response Relationship, Drug; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D008297:Male; D051379:Mice; D009420:Nervous System / Q000187:drug effects; D009422:Nervous System Diseases / Q000139:chemically induced; D012075:Remission, Spontaneous; D014747:Vinblastine / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D014750:Vincristine / Q000008:administration & dosage* / Q000627:therapeutic use
D014750:Vincristine; D014747:Vinblastine